Plunkett Research Online: Mirati Therapeutics Inc

MIRATI THERAPEUTICS INC (MRTX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mirati Therapeutics is an American biotechnology company. The company’s medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati’s drug candidates target specific genetic and epigenetic drivers of cancer. Its portfolio includes MGCD265, MGCD516, a.....



Mirati Therapeutics Inc
Ticker: MRTX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 332-3410
Fax:
Address: 9393 Towne Centre Drive
Suite 200
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Charles BaumCEO/Director/President
Jamie DonadioCFO/Chief Accounting Officer/Senior VP
See More
Mirati Therapeutics is an American biotechnology company. The company’s medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati’s drug candidates target specific genetic and epigenetic drivers of cancer. Its portfolio includes MGCD265, MGCD516, a.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: